Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treated advanced melanoma patients
Titel:
Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treated advanced melanoma patients
Auteur:
Karadurmus, Nuri Nahit Sendur, Mehmet Ali Karaca, Burcak Olmez, Omer Fatih Hacibekiroglu, Ilhan Coskun, Hasan Senol Degirmencioglu, Serkan Kemal, Yasemin Kilickap, Saadettin Sumbul, Ahmet Taner Aydin, Burc Turna, Hande Kaplan, Muhammet Ali Babacan, Nalan Demirci, Umut Ata, Alper Erdem, Dilek Ozet, Ahmet Abali, Huseyin